Overview

• A complaint filed on October 9, 2025 names the company and certain officers, alleging false or misleading statements during May 16, 2024 through August 5, 2025.
• Claims include selling over-the-counter instruments to itself, inconsistencies between subsidiaries and related parties, and financial statements that could not be relied upon.
• Faruqi & Faruqi, Rosen Law Firm, and Lowey Dannenberg are soliciting investors to move for lead-plaintiff status by December 8, 2025.
• The case references an August 5 NINGI Research report alleging off-balance-sheet entities, fictitious transactions, and concealed derivatives exposure, after which the stock fell 6.2%.
• No class has been certified and the allegations are unproven, with firms offering contingency-fee representation as the litigation remains in early stages.